NanoViricides
NNVC
44 hedge funds and large institutions have $2.85M invested in NanoViricides in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.
1.26% less ownership
Funds ownership: 5.96% → 4.7% (-1.3%)
2% less funds holding
Funds holding: 45 → 44 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
41% less capital inflows, than outflows
Capital inflows: $267K | Capital outflows: $454K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$133K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$61.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$20K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$11.1K |
| 5 |
Morgan Stanley
New York
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bridgeway Capital Management
Houston,
Texas
|
-$306K |
| 2 |
Lido Advisors
Los Angeles,
California
|
-$65K |
| 3 |
VF
Virtu Financial
New York
|
-$23.9K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19.2K |
| 5 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$13K |
NNVC Hedge Fund Activity: Q4 2017 in Review
44 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2017, worth a combined $2.85M — down 26% from $3.85M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NNVC and 4 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $133K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $306K sold.
- 44 institutional investors held NanoViricides (NNVC) as of Q4 2017, down from 45 in Q3 2017.
- Funds reported $2.85M of NanoViricides stock for Q4 2017, down 26% quarter-over-quarter.
- 4 funds opened new NanoViricides positions in Q4 2017 and 5 closed out, a net change of -1 holder.
- The largest NanoViricides buyer in Q4 2017 was Vanguard Group, an estimated $133K added.
- The largest NanoViricides seller in Q4 2017 was Bridgeway Capital Management, an estimated $306K sold.
Based on aggregated 13F filings for Q4 2017.